Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

被引:7
|
作者
Veldhuijzen, Evalien [1 ]
Walraven, Iris [2 ]
Belderbos, Jose [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands
来源
JMIR CANCER | 2021年 / 7卷 / 03期
关键词
PRO-CTCAE; lung cancer; side effects; patient-reported outcomes; PROM; symptomatic adverse events; QUALITY-OF-LIFE; CONTENT VALIDITY; CLINICAL-TRIALS; PRO; QUESTIONNAIRE; RELIABILITY; PREVALENCE; DISTRESS; THERAPY; QLQ-C30;
D O I
10.2196/26574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) item library covers a wide range of symptoms relevant to oncology care. There is a need to select a subset of items relevant to specific patient populations to enable the implementation of PRO-CTCAE-based symptom monitoring in clinical practice. Objective: The aim of this study is to develop a PRO-CTCAE-based subset relevant to patients with lung cancer that can be used for monitoring during multidisciplinary clinical practice. Methods: The PRO-CTCAE-based subset for patients with lung cancer was generated using a mixed methods approach based on the European Organization for Research and Treatment of Cancer guidelines for developing questionnaires, comprising a literature review and semistructured interviews with both patients with lung cancer and health care practitioners (HCPs). Both patients and HCPs were queried on the relevance and impact of all PRO-CTCAE items. The results were summarized, and after a final round of expert review, a selection of clinically relevant items for patients with lung cancer was made. Results: A heterogeneous group of patients with lung cancer (n=25) from different treatment modalities and HCPs (n=22) participated in the study. A final list of eight relevant PRO-CTCAE items was created: decreased appetite, cough, shortness of breath, fatigue, constipation, nausea, sadness, and pain (general). Conclusions: On the basis of the literature and both professional and patient input, a subset of PRO-CTCAE items has been identified for use in patients with lung cancer in clinical practice. Future work is needed to confirm the validity and effectiveness of this PRO-CTCAE-based lung cancer subset internationally and in real-world clinical practice settings.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] CAPTURING SYMPTOM BURDEN AND TREATMENT TOLERABILITY IN CANCER CLINICAL TRIALS: NCI'S PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)
    Mitchell, Sandra
    Castro, Kathleen
    St Germain, Diane
    Denicoff, Andrea
    Watkins-Bruner, Deborah
    O'Mara, Ann
    ONCOLOGY NURSING FORUM, 2013, 40 (06) : E454 - E454
  • [32] Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Lei Liu
    Tingting Suo
    Yongqing Shen
    Cuizhi Geng
    Zhengchuan Song
    Fengxia Liu
    Jianxin Wang
    Yanli Xie
    Yanshou Zhang
    Tiantian Tang
    Lina Zhang
    Weina Wang
    Quality of Life Research, 2020, 29 : 3009 - 3015
  • [33] Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Liu, Lei
    Suo, Tingting
    Shen, Yongqing
    Geng, Cuizhi
    Song, Zhengchuan
    Liu, Fengxia
    Wang, Jianxin
    Xie, Yanli
    Zhang, Yanshou
    Tang, Tiantian
    Zhang, Lina
    Wang, Weina
    QUALITY OF LIFE RESEARCH, 2020, 29 (11) : 3009 - 3015
  • [34] A pilot study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a phase I clinical trial
    Qin, Rui
    Dueck, Amylou C.
    Satele, Daniel
    Molina, Julian R.
    Erlichman, Charles
    Basch, Ethan M.
    Sloan, Jeff A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Validation of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women receiving treatment for metastatic breast cancer
    Mitchell, Sandra A.
    Lang, Kathy
    Nichols, Christine
    Clauser, Steven B.
    Federico, Victoria
    Lalla, Deepa
    Tripathy, Debu
    Hurvitz, Sara A.
    Castro, Kathleen M.
    Reeve, Bryce B.
    Rogak, Lauren J.
    Denicoff, Andrea
    Chen, Alice
    Piekarz, Richard
    Bennett, Antonia V.
    Atkinson, Thomas Michael
    O'Mara, Ann M.
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Benjamin Arnold
    Sandra A. Mitchell
    Lauren Lent
    Tito R. Mendoza
    Lauren J. Rogak
    Natalie M. Barragán
    Gordon Willis
    Mauricio Medina
    Suzanne Lechner
    Frank J. Penedo
    Jay K. Harness
    Ethan M. Basch
    Supportive Care in Cancer, 2016, 24 : 2843 - 2851
  • [37] Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048
    Basch, Ethan
    Dueck, Amylou C.
    Rogak, Lauren J.
    Mitchell, Sandra A.
    Minasian, Lori M.
    Denicoff, Andrea M.
    Wind, Jennifer K.
    Shaw, Mary C.
    Heon, Narre
    Shi, Qian
    Ginos, Brenda
    Nelson, Garth D.
    Meyers, Jeffrey P.
    Chang, George J.
    Mamon, Harvey J.
    Weiser, Martin R.
    Kolevska, Tatjana
    Reeve, Bryce B.
    Bruner, Deborah Watkins
    Schrag, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3120 - +
  • [38] Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Schroeder, Kristin M.
    Rizzieri, Tyler
    Lion, Ryan R.
    Mtenga, Norbert
    Gisiri, Mwitasrobert
    McFatrich, Molly
    Reeve, Bryce B.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [39] Refinement of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) via cognitive interviewing.
    Hay, J.
    Atkinson, T. M.
    Mendoza, T. R.
    Reeve, B. B.
    Willis, G.
    Gagne, J. J.
    Abernethy, A. P.
    Cleeland, C. S.
    Schrag, D.
    Basch, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Kristin M. Schroeder
    Tyler Rizzieri
    Ryan R. Lion
    Norbert Mtenga
    Mwitasrobert Gisiri
    Molly McFatrich
    Bryce B. Reeve
    Journal of Patient-Reported Outcomes, 7